207 related articles for article (PubMed ID: 28843848)
1. Depressive-like neurochemical and behavioral markers of Parkinson's disease after 6-OHDA administered unilaterally to the rat medial forebrain bundle.
Kamińska K; Lenda T; Konieczny J; Czarnecka A; Lorenc-Koci E
Pharmacol Rep; 2017 Oct; 69(5):985-994. PubMed ID: 28843848
[TBL] [Abstract][Full Text] [Related]
2. Induction of depressive-like behavior by intranigral 6-OHDA is directly correlated with deficits in striatal dopamine and hippocampal serotonin.
Santiago RM; Barbiero J; Gradowski RW; Bochen S; Lima MM; Da Cunha C; Andreatini R; Vital MA
Behav Brain Res; 2014 Feb; 259():70-7. PubMed ID: 24183944
[TBL] [Abstract][Full Text] [Related]
3. Effects of bromelain on motor responses following intra-medial forebrain bundle 6-OHDA injection in rat model of parkinsonism.
Adu TS; Mabandla MV
Metab Brain Dis; 2019 Dec; 34(6):1557-1564. PubMed ID: 31332728
[TBL] [Abstract][Full Text] [Related]
4. Serotonin₆ receptors in the dorsal hippocampus regulate depressive-like behaviors in unilateral 6-hydroxydopamine-lesioned Parkinson's rats.
Liu KC; Li JY; Tan HH; Du CX; Xie W; Zhang YM; Ma WL; Zhang L
Neuropharmacology; 2015 Aug; 95():290-8. PubMed ID: 25863121
[TBL] [Abstract][Full Text] [Related]
5. Behavioral and neurochemical interactions of the tricyclic antidepressant drug desipramine with L-DOPA in 6-OHDA-lesioned rats. Implications for motor and psychiatric functions in Parkinson's disease.
Kamińska K; Lenda T; Konieczny J; Lorenc-Koci E
Psychopharmacology (Berl); 2022 Nov; 239(11):3633-3656. PubMed ID: 36178508
[TBL] [Abstract][Full Text] [Related]
6. Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine.
Santiago RM; Barbieiro J; Lima MM; Dombrowski PA; Andreatini R; Vital MA
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1104-14. PubMed ID: 20547199
[TBL] [Abstract][Full Text] [Related]
7. Interactions of the tricyclic antidepressant drug amitriptyline with L-DOPA in the striatum and substantia nigra of unilaterally 6-OHDA-lesioned rats. Relevance to motor dysfunction in Parkinson's disease.
Kamińska K; Lenda T; Konieczny J; Wardas J; Lorenc-Koci E
Neurochem Int; 2018 Dec; 121():125-139. PubMed ID: 30290201
[TBL] [Abstract][Full Text] [Related]
8. Molsidomine, a nitric oxide donor, modulates rotational behavior and monoamine metabolism in 6-OHDA lesioned rats treated chronically with L-DOPA.
Lorenc-Koci E; Czarnecka A; Lenda T; Kamińska K; Konieczny J
Neurochem Int; 2013 Dec; 63(8):790-804. PubMed ID: 24090640
[TBL] [Abstract][Full Text] [Related]
9. Involvement of prelimbic 5-HT
Du CX; Guo Y; Zhang QJ; Zhang J; Lv SX; Liu J
Neurol Res; 2018 Oct; 40(10):847-855. PubMed ID: 29989483
[TBL] [Abstract][Full Text] [Related]
10. Nigrostriatal damage with 6-OHDA: validation of routinely applied procedures.
Fulceri F; Biagioni F; Lenzi P; Falleni A; Gesi M; Ruggieri S; Fornai F
Ann N Y Acad Sci; 2006 Aug; 1074():344-8. PubMed ID: 17105931
[TBL] [Abstract][Full Text] [Related]
11. Intracerebral administration of 2,4-diclorophenoxyacetic acid induces behavioral and neurochemical alterations in the rat brain.
Bortolozzi A; Evangelista de Duffard AM; Dajas F; Duffard R; Silveira R
Neurotoxicology; 2001 Apr; 22(2):221-32. PubMed ID: 11405254
[TBL] [Abstract][Full Text] [Related]
12. Activation and blockade of serotonin7 receptors in the prelimbic cortex regulate depressive-like behaviors in a 6-hydroxydopamine-induced Parkinson's disease rat model.
Zhang QJ; Du CX; Tan HH; Zhang L; Li LB; Zhang J; Niu XL; Liu J
Neuroscience; 2015 Dec; 311():45-55. PubMed ID: 26470809
[TBL] [Abstract][Full Text] [Related]
13. Estrogen interacts with the IGF-1 system to protect nigrostriatal dopamine and maintain motoric behavior after 6-hydroxdopamine lesions.
Quesada A; Micevych PE
J Neurosci Res; 2004 Jan; 75(1):107-16. PubMed ID: 14689453
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects of novel phosphatidylglycerol-based phospholipids in the 6-hydroxydopamine model of Parkinson's disease.
Crotty S; Fitzgerald P; Tuohy E; Harris DM; Fisher A; Mandel A; Bolton AE; Sullivan AM; Nolan Y
Eur J Neurosci; 2008 Jan; 27(2):294-300. PubMed ID: 18190522
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in rats.
Srinivasan J; Schmidt WJ
Eur J Neurosci; 2003 Jun; 17(12):2586-92. PubMed ID: 12823465
[TBL] [Abstract][Full Text] [Related]
16. Temporal Dissociation of Striatum and Prefrontal Cortex Uncouples Anhedonia and Defense Behaviors Relevant to Depression in 6-OHDA-Lesioned Rats.
Matheus FC; Rial D; Real JI; Lemos C; Takahashi RN; Bertoglio LJ; Cunha RA; Prediger RD
Mol Neurobiol; 2016 Aug; 53(6):3891-3899. PubMed ID: 26164273
[TBL] [Abstract][Full Text] [Related]
17. Anxiety-like behavior induced by 6-OHDA animal model of Parkinson's disease may be related to a dysregulation of neurotransmitter systems in brain areas related to anxiety.
Vieira JCF; Bassani TB; Santiago RM; de O Guaita G; Zanoveli JM; da Cunha C; Vital MABF
Behav Brain Res; 2019 Oct; 371():111981. PubMed ID: 31141725
[TBL] [Abstract][Full Text] [Related]
18. Temporal changes of dopaminergic and glutamatergic receptors in 6-hydroxydopamine-treated rat brain.
Araki T; Tanji H; Kato H; Imai Y; Mizugaki M; Itoyama Y
Eur Neuropsychopharmacol; 2000 Sep; 10(5):365-75. PubMed ID: 10974608
[TBL] [Abstract][Full Text] [Related]
19. Comparison of 6-hydroxydopamine-induced medial forebrain bundle and nigrostriatal terminal lesions in a lateralised nose-poking task in rats.
Dowd E; Dunnett SB
Behav Brain Res; 2005 Apr; 159(1):153-61. PubMed ID: 15795009
[TBL] [Abstract][Full Text] [Related]
20. Ginsenoside Rg1 protects dopaminergic neurons in a rat model of Parkinson's disease through the IGF-I receptor signalling pathway.
Xu L; Chen WF; Wong MS
Br J Pharmacol; 2009 Oct; 158(3):738-48. PubMed ID: 19703168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]